# Adcentrx Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/adcentrx-therapeutics

- Industry: Biotechnology
- Headquarters: San Diego, US
- Website: www.adcentrx.com
- Total disclosed funding: $101M
- Latest round: Series A (Dec 5, 2023)
- Investors on record: 10

## About

Based in California, US, and founded in 2021, Adcentrx Therapeutics is a biotechnology company focused on accelerating breakthroughs in antibody drug conjugate (ADC) therapeutic development. Adcentrx Therapeutics was founded by a veteran ADC team with extensive experience in ADC conjugation, target biology and CMC. The founder, Dr. Hui Li, was the CEO of Levena Biopharma, the ADC subsidiary of Sorrento Therapeutics. Dr. Pia Challita-Eid, head of research at Adcentrx, has led teams at Agensys, responsible for novel target and drug discovery. In April 2023, Adcentrx Therapeutics Inc. raise USD 38 million in series A funding led by Eight Roads Ventures, with participation from other ABio-X, Delta Capital, F-Prime Capital, Trinity Innovation Foundation.

By combining the targeting precision of biologics and the disease-fighting power of small molecule payloads, Adcentrx Therapeutics strives to develop next-generation targeted therapies for improving patient treatment options.

The company intends to use the April 2023 funding to proceed with the launch of its ADC therapeutic pipeline into the clinic.

## Funding rounds

- Series A, Dec 5, 2023, $13M — Eight Roads Ventures, Partners Investment, Quan Capital
- Series A, Apr 24, 2023, $38M — Eight Roads Ventures, F-Prime Capital, Delta Capital, Trinity Innovation Fund, ABio-X
- Series A, Apr 28, 2021, $50M — Boyu Capital, CBC Group, Zoo Capital

## Investors

- Boyu Capital (https://capitalatlas.ai/funds/boyu-capital) — Series A
- CBC Group (https://capitalatlas.ai/funds/cbc-group) — Series A
- Zoo Capital — Series A
- Eight Roads Ventures (https://capitalatlas.ai/funds/eight-roads-ventures) — Series A
- F-Prime Capital (https://capitalatlas.ai/funds/f-prime-capital) — Series A
- Delta Capital (https://capitalatlas.ai/funds/delta-capital) — Series A
- Trinity Innovation Fund (https://capitalatlas.ai/funds/trinity-innovation-fund) — Series A
- ABio-X — Series A
- Partners Investment (https://capitalatlas.ai/funds/partners-investment) — Series A
- Quan Capital (https://capitalatlas.ai/funds/quan-capital) — Series A